Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use of radioactive materials.
A radiopharmaceutical preparation is a medicinal product in a ready-to-use format containing a radionuclide suitable for human use. A kit for radiopharmaceutical preparation encloses a non-radionuclide components of a radiopharmaceutical preparation in a sterilized and validated form, to which the Radionuclide is added. Radiopharmaceuticals derived from kits are intended to be used within 12 hours of preparation.
Click To Continue Reading on Radiopharmaceuticals Market
There are over 40 radioisotopes available for use in different therapies. Technetium-99m is the most widely used radioisotope in the diagnostic procedure. Technetium-99m is used as a radioactive tracer and can be detected in the body by medical equipment (gamma cameras). It is well suited to the role, as it emits just detectable gamma rays with photon energy of 140 keV. According to International Atomic Energy Agency, more than 80% of the total nuclear diagnostic procedures are performed on a weekly basis, the technetium-99 as a radiotracer, propels the radiopharmaceuticals market growth.
Radiopharmaceuticals use in Diagnostic and Therapeutic Application fuels
The chemical and physical identity is of vital importance, as it does during administration of certain tissues, binding sites, and biochemical pathways. The market is divided into two major areas, namely, diagnostic and therapeutic. Therapeutic applications of radiopharmaceuticals market include cardiology (myocardial perfusion), oncology (tumor imaging and localization), and neurology (cerebral perfusion). Radiopharmaceuticals such as iodine-131 or iodine-125 labeled m-iodobenzyl guanidines (MIGB) are used to treat pheochromocytoma and neuroblastoma. The therapeutic segment of nuclear medicine can be further sub-segmented on the basis of procedure into beta emitters, alpha emitters, and brachytherapy.
Growth of the radiopharmaceuticals market is projected to witness rapid traction in the future due to its high potential in diagnosis and detection of diseases related to cardiology, neurology, and oncology. Developed regions are expected to be highly profitable markets for this technology, due to the high capital investment and availability of advanced medical facilities in these regions. Major players in the global positron emission tomography (PET) scanners market are concentrating on improving their global and regional presence through strategic operational expansion and collaborations with regional players.
Radiopharmaceuticals are widely used in North America, mainly due to availability of advanced healthcare infrastructure, technological advances, superior medical facilities, and supportive government support. These are also widely used in Europe due to new procedures for diagnosing diseases and robust medical infrastructure in the region. Radiopharmaceuticals market is projected to witness rampant growth in Asia due to rapid rise in research work in the sector and rising public awareness.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/70
Key Venors:
Kimberly-Clark Corporation, Eli Lilly and Company, Lantheus Medical Imaging Inc., Ampio Pharmaceuticals Inc., GE Healthcare, Piramal Imaging, Covidien Plc., Cardinal Health, Iso Tex Diagnostics, Inc., Jubilant DraxImage Inc., Bayer HealthCare Pharmaceuticals Inc , Bracco Diagnostic Inc., Navidea Biopharmaceuticals, Nordion Inc., Spectrum Pharmaceuticals, Inc., Mallinckrodt Plc., Bio-Nucleonics Inc., and IBA-Molecular.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through emerging market trends, technologies, and potential absolute dollar opportunities.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, # 3200
Seattle, WA 98154
Tel: + 1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news site: https://www.coherentwire.com